Demand for rapid on-site evaluation (ROSE) of fine needle aspiration cytology (FNAC) samples has continued to grow in Australia, as well as many other countries, and this is now an important role for cytologists in both public and private healthcare sectors. 1,2 ROSE may result in reduced non-diagnostic and indeterminant reports, reduced needle passes per procedure, improved clinician-laboratory communication, and optimal specimen handling. [2][3][4] Reducing the number of needle passes may shorten the procedure time resulting in cost savings and potentially less complications. However, the time demands placed on the laboratory are considerable.Several studies have demonstrated this role may be performed by adequately trained scientific staff, 1,2,5 reducing the need for